# Study of EGFR-TKI to Asymptomatic Brain Metastases of NSCLC

> **NCT02250846** · PHASE2 · UNKNOWN · sponsor: **Union Hospital, Tongji Medical College, Huazhong University of Science and Technology** · enrollment: 70 (estimated)

## Conditions studied

- Asymptomatic Brain Metastases of Non Small Cell Lung Cancer

## Interventions

- **DRUG:** EGFR-TKI

## Key facts

- **NCT ID:** NCT02250846
- **Lead sponsor:** Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2016-01
- **Final completion:** 2017-01
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2014-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02250846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02250846, "Study of EGFR-TKI to Asymptomatic Brain Metastases of NSCLC". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02250846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*